Nectar Lifescience Ltd.
BSE: 532649 | Sector: Health care |
NSE: NECLIFE | ISIN Code: INE023H01027 |
BSE 00:00 | 20 Mar | 16.27 |
0 (0.00%) |
OPEN
16.35 |
HIGH
16.40 |
LOW
16.08 |
NSE 00:00 | 20 Mar | 16.25 |
-0.05 (-0.31%) |
OPEN
16.20 |
HIGH
16.50 |
LOW
16.05 |
OPEN | 16.35 |
PREVIOUS CLOSE | 16.27 |
VOLUME | 26524 |
52-Week high | 34.10 |
52-Week low | 15.89 |
P/E | |
Mkt Cap.(Rs cr) | 365 |
Buy Price | 0.00 |
Buy Qty | 0.00 |
Sell Price | 0.00 |
Sell Qty | 0.00 |
- Financial Overview
- Balance Sheet
- Profit & Loss
- Cash Flow
- Ratios
- Quarterly
- Half Yearly
- Nine Monthly
- Yearly
Filter:
Nectar Lifescience Ltd. (NECLIFE) - Yearly Result
Particulars (![]() |
Mar '22 | Mar '21 | Mar '20 | Mar '19 | Mar '18 |
Net Sales/Income From Operations | 1668.26 | 1542.90 | 2363.16 | 2785.01 | 1875.98 |
Other Income | 11.29 | 2.72 | 4.01 | 5.96 | 5.58 |
Total Income | 1679.55 | 1545.62 | 2367.16 | 2790.97 | 1881.57 |
Total Expenditure | 1509.42 | 1457.98 | 2144.83 | 2521.03 | 1639.49 |
Operating Profit | 170.13 | 87.64 | 222.33 | 269.94 | 242.08 |
Interest | 78.81 | 112.03 | 125.82 | 148.13 | 115.20 |
Gross Profit | 91.32 | -24.40 | 96.51 | 121.81 | 126.87 |
Depreciation | 56.97 | 60.25 | 60.77 | 63.26 | 64.31 |
PBT | 34.35 | -84.65 | 35.74 | 58.55 | 62.56 |
Tax | 0.00 | 8.59 | 1.66 | 7.41 | 6.32 |
Net Profit/(Loss) | 25.32 | -73.15 | 30.06 | 47.33 | 52.15 |
Minority Interest After NP | - | - | - | - | - |
Net Profit after Minority Interest | - | - | - | - | - |
Exceptional Items | 0.00 | -22.75 | 0.00 | 0.00 | 0.00 |
Profit After Exceptional Items | 25.32 | -50.40 | 30.06 | 47.33 | 52.15 |
Equity Share Capital | 22.43 | 22.43 | 22.43 | 22.43 | 22.43 |
Reserves Excluding Revaluation Reserves | 1064.44 | 0.00 | 1112.18 | 1082.21 | 0.00 |
EPS | |||||
Basic EPS | 1.17 | -3.26 | 1.34 | 2.11 | 2.33 |
Public Share Holding | |||||
No Of Shares (Crores) | 0 | 0 | 0 | 0 | 0 |
Share Holding (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Promoters and Promoter Group Shareholding | |||||
a) Pledged/Encumbered | |||||
- Number of Shares (Crores) | 0 | 0 | 0 | 0 | 0 |
- Per. of Shares (as a % of the total sh. of prom. and promoter group) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
- Per. of Shares (as a % of the total Share Cap. of the company) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
b) Non-encumbered | |||||
- Number of Shares (Crores) | 0 | 0 | 0 | 0 | 0 |
- Per. of shares (as a % of the total sh. of prom. and promoter group) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
- Per. of shares (as a % of the total Share Cap. of the company) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Note : | PBT include deferred tax and fringe benefit tax Net profit figures include extra-ordinary items income/expenditure. |
Quick Links for Nectar Lifescience:
-
News
Announcements Brokerage Reports Business Earnings Sector -
Corporate Action
AGM Board Meetings Bonus Dividends EGM Rights Split -
INFORMATION
Bulk Deals Company History MF Holding Listing Info Locations Shareholding -
Financials
Financial Overview Balance Sheet Profit & Loss Cash Flow Ratios Quarterly Results Half Yearly Results Nine Monthly Results Yearly Results -
Annual Report
Auditors Report Chairman's Speech Company Management Directors' Report Finished Goods Raw Materials -
Peer Comparison
Competition Market Cap Price Price Performance Net Sales Net Profit Total Assets Historical Prices